# Worth Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/worth-medical

- Industry: Healthcare Specialists
- Headquarters: Hangzhou, China
- Latest round: Series A (Jul 25, 2024)
- Investors on record: 3

## About

Established in 2021 and based in Hangzhou, China, Worth Medical is a scoliosis disease treatment service provider, mainly focusing on non-invasive treatment for idiopathic scoliosis disease. In 2022, the company established a joint research center with the Shanghai Institute for Advanced Studies of Zhejiang University, and set up a joint project with the First People's Hospital of Hangzhou in 2023. As of 2024, the company has opened offline clinics in Hangzhou, Shenzhen, Chongqing and other cities. In December 2024, the firm closed venture funding from new investor Yuansu Fund.

 The company develops therapies and therapeutic devices for idiopathic scoliosis. The specific therapy is the Brain Learning Training Method (BLTM), which is a non-invasive, conservative treatment for patients with idiopathic scoliosis at the neural level of the brain rather than at the level of the skeletal muscles. The company has also developed wearable sensing Class II and Class III medical devices to provide scoliosis correction.

The company generates revenue by opening outpatient clinics and developing medical devices to treat idiopathic scoliosis.

## Funding rounds

- Series A, Jul 25, 2024 — Hangzhou Xihu District Science and Technology Equity Investment, Insight Capital, Jucheng Assets

## Investors

- Hangzhou Xihu District Science and Technology Equity Investment — Series A
- Insight Capital — Series A
- Jucheng Assets — Series A